This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
PERHAPS THE BEST way to introduce the Medical Dermatology Society (MDS) is with a presentation of its mission statement:
The Medical Dermatology Society was established in 1994 to foster interest and cooperative, patient-centered research in adult medical dermatology. In this context, the term "medical dermatology" is used to refer to cutaneous changes that are associated with systemic disease processes and to potentially disabling or fatal skin diseases that are treated primarily with systemic drug therapy. Specific diseases of interest include but are not limited to: autoimmune bullous disorders (pemphigus, pemphigoid), cutaneous T-cell lymphoma, severe drug hypersensitivity reactions (Stevens-Johnson Syndrome, toxic erythema necrolysis, the sulfone hypersensitivity syndrome), neutrophilic dermatoses, and rheumatic skin disease (lupus erythematosus, dermatomyositis, scleroderma and vasculitis).
Priorities of the Medical Dermatology Society include:
Foster interest and continuing education in medical dermatology among dermatologists and dermatology resident trainees
Serve as a coordinating body for the development of
Richard D. Sontheimer, Victoria Werth, Thomas T. Provost. The Medical Dermatology Society. Arch Dermatol. 1996;132(11):1373–1374. doi:10.1001/archderm.1996.03890350117021